Francisco D. Salva is a member of Vincerx’s board of directors. Mr Salva has served as an operating partner of Accelerator Life Science Partners, a venture capital firm, since January 2018, and served as president and chief executive officer of Complexa Inc., a clinical-stage biopharmaceutical company, from May 2018 to August 2020. Mr Salva co-founded Acerta Pharma and served as its vice president of operations from February 2013 to November 2016. Before that, Mr Salva served as senior director of corporate finance at Pharmacyclics. Mr Salva received an AB in business economics and an AB in philosophy from Brown University and a MSc in economics and philosophy form the London School of Economics.